Senior insider sale
Chief Medical Officer at CUE BIOPHARMA, INC. — senior position signals high conviction
$1.9K
7.23K shares
What this filing means
LEVISETTI MATTEO plans to sell 7.23K shares of CUE BIOPHARMA, INC. valued at approximately $1.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001950047-25-010720
Officer· Chief Medical Officer
Since Jan 2023
7.23K
Shares to sell
$1.9K
Approx. market value
7.23K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Open Market Purchase
Cash
9/21/2021
7.23KTotal acquired7.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/21/2021 | Open Market Purchase Cash | 7.23K | — |
| Total | 7.23K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.23K
Market value
$1.9K
12/29/2025
Total
Units
7.23K
Value
$1.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/29/2025 | 7.23K | $1.9K | NASDAQ | Planned |
| Total | 7.23K | $1.9K | ||